because this is all IP and early stage stuff. It may have a TAM of 400B but it takes decades to get products from pre-clinical to bedside. And there is no guarantee that any drug will take out any of addressable market. It is not as if it is to be valued at 400B.
Ann: Incannex to Acquire APIRx Pharmaceuticals, page-33
-
- There are more pages in this discussion • 428 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)